{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T03:15:33Z","timestamp":1767928533130,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007059","name":"Univerzita Palack\u00e9ho v Olomouci","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007059","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ejmech.2019.111812","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T09:19:20Z","timestamp":1572945560000},"page":"111812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Novel thiazolidinedione-hydroxamates as inhibitors of Mycobacterium tuberculosis virulence factor Zmp1"],"prefix":"10.1016","volume":"185","author":[{"given":"Veronika","family":"\u0160lachtov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"\u0160ebela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3451-0354","authenticated-orcid":false,"given":"Eveline","family":"Torfs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Oorts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davie","family":"Cappoen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9472-2589","authenticated-orcid":false,"given":"Karel","family":"Berka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3393-3010","authenticated-orcid":false,"given":"V\u00e1clav","family":"Bazgier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8380-073X","authenticated-orcid":false,"given":"Lucie","family":"Brul\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111812_bib1","doi-asserted-by":"crossref","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","article-title":"Tuberculosis","volume":"2","author":"Pai","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejmech.2019.111812_bib2","series-title":"Global Tuberculosis Report 2018","author":"World Health Organization (WHO)","year":"2018"},{"key":"10.1016\/j.ejmech.2019.111812_bib3","series-title":"WHO Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment","author":"World Health Organization (WHO)","year":"2019"},{"key":"10.1016\/j.ejmech.2019.111812_bib4","series-title":"Implementing the End TB Strategy: the Essentials","author":"World Health Organization (WHO)","year":"2015"},{"key":"10.1016\/j.ejmech.2019.111812_bib5","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/resp.13345","article-title":"New drugs and regimens for tuberculosis","volume":"23","author":"Chang","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.ejmech.2019.111812_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2017.03.028","article-title":"Anti-tubercular drug discovery: in silico implications and challenges","volume":"104","author":"Mehra","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2019.111812_bib7","doi-asserted-by":"crossref","first-page":"32475","DOI":"10.1074\/jbc.M111.271809","article-title":"Crystal structure of Mycobacterium tuberculosis zinc-dependent metalloprotease-1 (Zmp1), a metalloprotease involved in pathogenicity","volume":"286","author":"Ferraris","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111812_bib8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.chom.2008.03.003","article-title":"Mycobacterium tuberculosis prevents inflammasome activation","volume":"3","author":"Master","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2019.111812_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.chom.2008.03.006","article-title":"Linking inflammasome activation and phagosome maturation","volume":"3","author":"Lazarevic","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2019.111812_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens7010017","article-title":"Mycobacterium tuberculosis molecular determinants of infection, survival strategies, and vulnerable targets","volume":"7","author":"Ferraris","year":"2018","journal-title":"Pathogens"},{"key":"10.1016\/j.ejmech.2019.111812_bib11","series-title":"Zinc-dependent Metalloprotease-1 (Zmp1)","first-page":"1","author":"Ferraris","year":"2013"},{"key":"10.1016\/j.ejmech.2019.111812_bib12","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1365-2958.2005.05036.x","article-title":"Structure of the Mycobacterium tuberculosis proteasome and mechanism of inhibition by a peptidyl boronate","volume":"59","author":"Hu","year":"2006","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ejmech.2019.111812_bib13","doi-asserted-by":"crossref","first-page":"14831","DOI":"10.1074\/jbc.275.20.14831","article-title":"Why does threonine, and not serine, function as the active site nucleophile in proteasomes?","volume":"275","author":"Kisselev","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111812_bib14","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.bmcl.2014.04.004","article-title":"Discovery of the first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor","volume":"24","author":"Mori","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111812_bib15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bmcl.2018.01.031","article-title":"Design, synthesis, SAR and biological investigation of 3-(carboxymethyl)rhodanine and aminothiazole inhibitors of Mycobacterium tuberculosis Zmp1","volume":"28","author":"Mori","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111812_bib16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/cmdc.201700759","article-title":"Development of potent inhibitors of the Mycobacterium tuberculosis virulence factor Zmp1 and evaluation of their effect on mycobacterial survival inside macrophages","volume":"13","author":"Paolino","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.111812_bib17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ejmech.2016.09.059","article-title":"Quinolidene-rhodanine conjugates: facile synthesis and biological evaluation","volume":"125","author":"Subhedar","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111812_bib18","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.bmcl.2016.03.045","article-title":"Novel tetrazoloquinoline-rhodanine conjugates: highly efficient synthesis and biological evaluation","volume":"26","author":"Subhedar","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111812_bib19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.bmcl.2014.01.007","article-title":"Antimycobacterial evaluation of novel hybrid arylidene thiazolidine-2,4-diones","volume":"24","author":"Ponnuchamy","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"9","key":"10.1016\/j.ejmech.2019.111812_bib20","first-page":"993","article-title":"Synthesis of newer 5-benzylidene-2,4-thiazolidinediones as potential antimicrobials","volume":"2","author":"Patel","year":"2014","journal-title":"Indian J. Res. Pharm. Biotechnol."},{"key":"10.1016\/j.ejmech.2019.111812_bib21","first-page":"496","article-title":"Synthesis of new thiazolidine-2,4-dione derivatives and their antimicrobial and antitubercular activity","volume":"1","author":"Shaikh","year":"2013","journal-title":"Indian J. Res. Pharm. Biotechnol."},{"key":"10.1016\/j.ejmech.2019.111812_bib22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbamcr.2009.08.006","article-title":"To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition","volume":"1803","author":"Jacobsen","year":"2010","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ejmech.2019.111812_bib23","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1016\/j.bmcl.2015.04.099","article-title":"Syntheses and evaluation of substituted aromatic hydroxamates and hydroxamic acids that target Mycobacterium tuberculosis","volume":"25","author":"Majewski","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111812_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bmc.2006.10.010","article-title":"A\u00a0library of novel hydroxamic acids targeting the metallo-protease family: design, parallel synthesis and screening","volume":"15","author":"Flipo","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111812_bib25","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.1021\/jo990769y","article-title":"Practical synthesis of hydroxamate-derived siderophore components by an indirect oxidation method and syntheses of a DIG-siderophore conjugate and a biotin-siderophore conjugate","volume":"64","author":"Lin","year":"1999","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111812_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bioorg.2014.05.006","article-title":"Design, synthesis and glucose uptake activity of some novel glitazones","volume":"56","author":"Kar","year":"2014","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.111812_bib27","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1016\/j.tetlet.2014.06.082","article-title":"Acetic anhydride-promoted one-pot condensation of 2,4-thiazolidinedione with bisulfite adducts of aldehydes","volume":"55","author":"Mohanty","year":"2014","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2019.111812_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1039\/C0NJ00691B","article-title":"Synthesis of 5-arylidene-2,4-thiazolidinediones by Knoevenagel condensation catalyzed by Baker\u2019s yeast","volume":"35","author":"Pratap","year":"2011","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2019.111812_bib29","doi-asserted-by":"crossref","first-page":"W200","DOI":"10.1093\/nar\/gkv353","article-title":"FAF-Drugs3: a web server for compound property calculation and chemical library design","volume":"43","author":"Lagorce","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2019.111812_bib30","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1021\/ci300367a","article-title":"admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties","volume":"52","author":"Cheng","year":"2012","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2019.111812_bib31","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/cbdd.12788","article-title":"Design, synthesis and biological evaluation of novel quinoline-based carboxylic hydrazides as anti-tubercular agents","volume":"88","author":"Chander","year":"2016","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2019.111812_bib32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/cbdd.12788","article-title":"Design, synthesis and biological evaluation of novel quinoline-based carboxylic hydrazides as anti-tubercular agents","volume":"88","author":"Chander","year":"2016","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2019.111812_bib33","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0960-894X(00)00172-4","article-title":"Prediction of drug solubility from Monte Carlo simulations","volume":"10","author":"Jorgensen","year":"2000","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111812_bib34","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"issue":"Suppl 48","key":"10.1016\/j.ejmech.2019.111812_bib35","doi-asserted-by":"crossref","first-page":"90S","DOI":"10.1042\/CS103S090S","article-title":"Characterization of PgPepO, a bacterial homologue of endothelin-converting enzyme-1","volume":"103","author":"Carson","year":"2002","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.ejmech.2019.111812_bib36","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1044-0305(02)00426-9","article-title":"Practical quantitative biomedical applications of MALDI-TOF mass spectrometry","volume":"13","author":"Bucknall","year":"2002","journal-title":"J.\u00a0Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.ejmech.2019.111812_bib37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jasms.2006.09.013","article-title":"MALDI TOF\/TOF tandem mass spectrometry as a new tool for amino acid analysis","volume":"18","author":"Gogichaeva","year":"2007","journal-title":"J.\u00a0Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.ejmech.2019.111812_bib38","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/1472-6882-14-400","article-title":"Identification of plant-derived natural products as potential inhibitors of the Mycobacterium tuberculosis proteasome","volume":"14","author":"Zheng","year":"2014","journal-title":"BMC Complement Altern. Med."},{"key":"10.1016\/j.ejmech.2019.111812_bib39","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/cbdd.13087","article-title":"Synthesis and in\u00a0vitro investigation of halogenated 1,3-bis(4-nitrophenyl)triazenide salts as antitubercular compounds","volume":"91","author":"Torfs","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2019.111812_bib40","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1039\/C8OB02690D","article-title":"Synthesis and antitubercular activity of 1- and 3-substituted benzo[g]isoquinoline-5,10-diones","volume":"17","author":"Smets","year":"2019","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2019.111812_bib41","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1021\/jm401735w","article-title":"1,2,3,4,8,9,10,11-Octahydrobenzo[j]phenanthridine-7,12-diones as New Leads against Mycobacterium tuberculosis","volume":"57","author":"Cappoen","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111812_bib42","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1021\/jm048957q","article-title":"The PDBbind database: methodologies and updates","volume":"48","author":"Wang","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111812_bib43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/jmbi.1999.3492","article-title":"Structure of human neutral endopeptidase (neprilysin) complexed with phosphoramidon","volume":"296","author":"Oefner","year":"2000","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2019.111812_bib44","doi-asserted-by":"crossref","first-page":"17979","DOI":"10.1073\/pnas.0605865103","article-title":"Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways","volume":"103","author":"Wisner","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.111812_bib45","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2019.111812_bib46","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J.\u00a0Comput. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341930964X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341930964X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:02:38Z","timestamp":1759327358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352341930964X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":46,"alternative-id":["S022352341930964X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111812","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel thiazolidinedione-hydroxamates as inhibitors of Mycobacterium tuberculosis virulence factor Zmp1","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111812","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111812"}}